The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take...

Published on 10 Oct 2021 on Benzinga

The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take...

Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive stocks and into risky bets amid the broader market strength.

Vaccine stocks continued to experience selling pressure in the week. Data readouts and presentations at conferences also moved stocks in either direction.

Read the rest of the article

NASDAQ.DTIL price evolution

NYSE.LLY price evolution

NYSE.ENZ price evolution

NASDAQ.APLT price evolution

NASDAQ.ATRA price evolution

NASDAQ.AVDL price evolution

NASDAQ.ALLO price evolution

TSX.TH price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies

Eli Lilly and Company LLY announced that its pipeline candidate, tirzepatide, met all primary and...

Zacks via Yahoo Finance 18 Apr 2024

Company News for Apr 18, 2024

Eli Lilly and Company (LLY) shares rose 0.5% after announcing positive late-stage results for its...

Zacks via Yahoo Finance 18 Apr 2024

14 Best Large Cap Dividend Growth Stocks To Buy Now

In this article, we discuss 14 best large-cap dividend growth stocks to buy now. You can skip our...

Insider Monkey via Yahoo Finance 18 Apr 2024

Eli Lilly's Mounjaro, Zepbound to remain in shortage through end of Q2 (NYSE:LLY)

Eli Lilly's semaglutide-based drugs for diabetes and weight loss, Mounjaro and Zepbound, will fac...

Seeking Alpha 17 Apr 2024

Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says

Zepbound, a popular weight loss drug, also seems to help people with obstructive sleep apnea,...

CNN.com 17 Apr 2024

The Week in Pictures: April 5 - April 12

From the ongoing conflict between Israel and Hamas, to UEFA Champions League quarter finals, to t...

dpa international via Yahoo News 12 Apr 2024

GLP-1s benefit Parkinson’s: Barclays sees biopharma impact

Barclays cites implications for the biopharma sector after a mid-stage trial showed that the GLP-...

Seeking Alpha 12 Apr 2024

Trillion-Dollar Trajectories: 3 Billion-Dollar Stocks With the Potential to Hit the Next Milestone

Reaching the trillion-dollar market cap is a testament to any company’s international influence,...

InvestorPlace 11 Apr 2024

Jim Cramer Stands By Nvidia And Eli Lilly Despite Market Dips, Says 'Terrific Time To Take Some...

Jim Cramer, CNBC’s market commentator, recently shared his insights on Tuesday’s market activity....

Benzinga 9 Apr 2024

Eli Lilly eyes $2.5B plant to make obesity drugs (NYSE:LLY)

Eli Lilly (LLY) begins construction of a $2.5B manufacturing plant in Germany to meet demand for ...

Seeking Alpha 9 Apr 2024